Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

PHA Partners & Events

10 Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

November 2, 2018

Hilton Durham near Duke University
3800 Hillsborough Rd
Durham, NC 27708
United States

The field of pulmonary arterial hypertension is a rapidly developing one, with multiple new treatments introduced in the last 20 years. This has created a steep learning curve for pulmonologists and cardiologists treating this disease, as well as primary care physicians who must remain mindful to consider the diagnosis in their patients. We seek to fortify the knowledge base of these physicians and other allied health professionals, keeping them abreast of the ever-changing diagnostic and treatment paradigms. This dynamic state of the field serves to perpetuate a gap in regard to the knowledge of appropriate diagnostic procedures, proper treatment choices, and timing in advancement of care to pulmonary hypertension specialty centers. It is imperative that those treating this specialized disease have a thoroughly grounded knowledge of the appropriate work up, treatment, and care of the Pulmonary Arterial Hypertension patients.

The ACCP, AHA, and WHO have convened on multiple occasions to develop consensus guidelines for the diagnosis and treatment of Pulmonary Arterial Hypertension (PAH). These guidelines have been published in prominent medical journals and presented at national meetings, thus exposing thousands of practitioners to these standardized approaches and promoting appropriate, structured care paradigms. The 10th annual RTP PH symposium will reinforce the current diagnostic and management guidelines of PAH put forth by the 5th and 6th World Symposium on Pulmonary Hypertension, along with the focus on the different subgroups of Pulmonary Hypertension. The diagnosis, management, and treatment for patients with WHO group 2-5 PH will be addressed. Also discussion will focus on medications for Pulmonary Hypertension that are available and the use of these in groups 2 and 3 PH will be addressed. It will provide a plentiful forum for questions and discussion, so that practitioners and health care providers in attendance can have knowledge and reinforcement of appropriate care practices that can be put into practice.

More Information:

Contact Information: Christy Darnell
Administrative Director, Duke Cardiology CME